These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25506198)

  • 1. Trial prospector: matching patients with cancer research studies using an automated and scalable approach.
    Sahoo SS; Tao S; Parchman A; Luo Z; Cui L; Mergler P; Lanese R; Barnholtz-Sloan JS; Meropol NJ; Zhang GQ
    Cancer Inform; 2014; 13():157-66. PubMed ID: 25506198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.
    Ni Y; Wright J; Perentesis J; Lingren T; Deleger L; Kaiser M; Kohane I; Solti I
    BMC Med Inform Decis Mak; 2015 Apr; 15():28. PubMed ID: 25881112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.
    Mantripragada KC; Olszewski AJ; Schumacher A; Perez K; Birnbaum A; Reagan JL; Mega A; Khurshid H; Bartley C; Lombardo A; Rossiter R; Papa A; Bakalarski P; Safran H
    J Oncol Pract; 2016 Apr; 12(4):e396-404. PubMed ID: 26907448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an artificial intelligence clinical trial matching system in Australian lung cancer patients.
    Alexander M; Solomon B; Ball DL; Sheerin M; Dankwa-Mullan I; Preininger AM; Jackson GP; Herath DM
    JAMIA Open; 2020 Jul; 3(2):209-215. PubMed ID: 32734161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors and outcomes of decision making for cancer clinical trial participation.
    Biedrzycki BA
    Oncol Nurs Forum; 2011 Sep; 38(5):542-52. PubMed ID: 21875841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.
    Filion M; Forget G; Brochu O; Provencher L; Desbiens C; Doyle C; Poirier B; DuRocher M; Camden S; Lemieux J
    Clin Trials; 2012 Oct; 9(5):652-9. PubMed ID: 23060323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials.
    Fern LA; Lewandowski JA; Coxon KM; Whelan J;
    Lancet Oncol; 2014 Jul; 15(8):e341-50. PubMed ID: 24988937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
    Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
    J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to participation in clinical trials: a physician survey.
    Mahmud A; Zalay O; Springer A; Arts K; Eisenhauer E
    Curr Oncol; 2018 Apr; 25(2):119-125. PubMed ID: 29719427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimedia psychoeducation for patients with cancer who are eligible for clinical trials: A randomized clinical trial.
    Kamen CS; Quinn GP; Asare M; Heckler CE; Guido JJ; Giguere JK; Gilliland K; Liu JJ; Geer J; Delacroix SE; Morrow GR; Jacobsen PB
    Cancer; 2018 Dec; 124(23):4504-4511. PubMed ID: 30291797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated matching software for clinical trials eligibility: measuring efficiency and flexibility.
    Penberthy L; Brown R; Puma F; Dahman B
    Contemp Clin Trials; 2010 May; 31(3):207-17. PubMed ID: 20230913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.
    Holmes DR; Major J; Lyonga DE; Alleyne RS; Clayton SM
    Am J Surg; 2012 Apr; 203(4):415-22. PubMed ID: 21996347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing reuse of structured eligibility criteria and supporting their relaxation.
    Milian K; Hoekstra R; Bucur A; Ten Teije A; van Harmelen F; Paulissen J
    J Biomed Inform; 2015 Aug; 56():205-19. PubMed ID: 26015310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matching Patients to Accelerate Clinical Trials (MPACT): Enabling Technology for Oncology Clinical Trial Workflow.
    Do NV; Elbers DC; Fillmore NR; Ajjarapu S; Bergstrom SJ; Bihn J; Corrigan JK; Dhond R; Dipietro S; Dolgin A; Feldman TC; Goryachev SD; Huhmann LB; La J; Marcantonio PA; McGrath KM; Miller SJ; Nguyen VQ; Schneeloch GR; Sung FC; Swinnerton KN; Tarren AH; Tosi HM; Valley D; Vo AD; Yildirim C; Zheng C; Zwolinski R; Sarosy GA; Loose D; Shannon C; Brophy MT
    Stud Health Technol Inform; 2024 Jan; 310():1086-1090. PubMed ID: 38269982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.